Sigma-2 receptor ligands: Neurobiological effects

Current Medicinal Chemistry

Volumn 22, Issue 8, 2015, Pages 989-1003

  Guo, Lin ^a   Zhen, Xuechu ^a  

^a SOOCHOW UNIVERSITY   (China)

Author keywords

Addiction; Calcium; Neuroprotection; Probe; Sigma 2 receptor

Indexed keywords

4 PHENYL PIPERIDINE DERIVATIVE; 7 AZABICYCLO[2.2.1]HEPTANE DERIVATIVE; 9 AZABICYCLO(3.3.1)NONAN 3 ALPHA YL CARBAMATE DERIVATIVE; AFOBAZOLE; BENZAMIDE DERIVATIVE; BENZOXAZOLONE; BENZYLIDENEPHENYLMORPHAN DERIVATIVE; CALCIUM; CENTRAL NERVOUS SYSTEM AGENTS; DITOLYL GUANIDINE; GUANIDINE DERIVATIVE; HEPTANE DERIVATIVE; IBOGAINE; INDOLE DERIVATIVE; N ALLYLNORMETAZOCINE; N SUBSTITUTED CYCLOHEXYLPIPERAZINE DERIVATIVE; NEUROPROTECTIVE AGENT; PENTAZOCINE; PIPERAZINE DERIVATIVE; PIPERIDINE DERIVATIVE; SIGMA 2 OPIATE RECEPTOR; SIGMA 2 RECEPTOR LIGAND; UNCLASSIFIED DRUG; LIGAND; SIGMA OPIATE RECEPTOR; SIGMA-2 RECEPTOR;

ADDICTION; ANXIETY; ARTICLE; CALCIUM CELL LEVEL; CENTRAL NERVOUS SYSTEM; CEREBROVASCULAR ACCIDENT; DEPRESSION; DOPAMINERGIC NERVE CELL; DRUG BINDING; DRUG SELECTIVITY; DRUG STRUCTURE; HUMAN; INFLAMMATION; MICROGLIA; NONHUMAN; ANIMAL; METABOLISM;

ANIMALS; CENTRAL NERVOUS SYSTEM; HUMANS; LIGANDS; RECEPTORS, SIGMA;

EID: 84931275455     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/0929867322666150114163607     Document Type: Article

References (82)

1. Pal, A.; Hajipour, A. R.; Fontanilla, D.; Ramachandran, S.; Chu, U. B.; Mavlyutov, T.; Ruoho, A. E. Identification of regions of the sigma-1 receptor ligand binding site using a novel photoprobe. Mol. Pharmacol., 2007, 72(4), 921-933.
2. Hellewell, S. B.; Bruce, A.; Feinstein, G.; Orringer, J.; Williams, W.; Bowen, W. D. Rat liver and kidney contain high densities of sigma 1 and sigma 2 receptors: characterization by ligand binding and photoaffinity labeling. Eur. J. Pharmacol., 1994, 268(1), 9-18.
3. Xu, J.; Zeng, C.; Chu, W.; Pan, F.; Rothfuss, J. M.; Zhang, F.; Tu, Z.; Zhou, D.; Zeng, D.; Vangveravong, S.; Johnston, F.; Spitzer, D.; Chang, K. C.; Hotchkiss, R. S.; Hawkins, W. G.; Wheeler, K. T.; Mach, R. H. Identification of the PGRMC1 protein complex as the putative sigma-2 receptor binding site. Nat. Commun., 2011, 2, 380. http://www. nature. com/ncomms/journal/v2/n7/full/ncomms1386. html
4. Bali, N.; Morgan, T. E.; Finch, C. E. Pgrmc1: new roles in the microglial mediation of progesterone-antagonism of estradioldependent neurite sprouting and in microglial activation. Front. Neurosci., 2013, 7, 157. http://journal. frontiersin. org/Journal/10. 3389/fnins. 2013. 00157/full
5. Mach, R. H.; Zeng, C.; Hawkins, W. G. The sigma2 receptor: A novel protein for the imaging and treatment of cancer. J. Med. Chem., 2013, 56(18), 7137-7160.
6. Abate, C.; Perrone, R.; Berardi, F. Classes of sigma2 (sigma2) receptor ligands: structure affinity relationship (SAfiR) studies and antiproliferative activity. Curr. Pharm. Des., 2012, 18(7), 938-949.
7. Prezzavento, O.; Gualtieri, F.; Marrazzo, A.; Romanelli, M. N.; Ronsisvalle, G.; Teodori, E. Sigma receptor binding profile of a series of analgesic tropane derivatives. Arch. Pharm. (Weinheim), 2002, 335(1), 39-43.
8. Nakazawa, M.; Kobayashi, T.; Matsuno, K.; Mita, S. Possible involvement of a sigma receptor subtype in the neck dystonia in rats. Pharmacol. Biochem. Behav., 1999, 62(1), 123-126.
9. Ghelardini, C.; Galeotti, N.; Bartolini, A. Pharmacological identification of SM-21, the novel sigma(2) antagonist. Pharmacol. Biochem. Behav., 2000, 67(3), 659-662.
10. Colabufo, N. A.; Berardi, F.; Contino, M.; Perrone, R.; Tortorella, V. A new method for evaluating sigma(2) ligand activity in the isolated guinea-pig bladder. Naunyn. Schmiedebergs. Arch. Pharmacol., 2003, 368(2), 106-112.
11. Zeng, C.; Rothfuss, J. M.; Zhang, J.; Vangveravong, S.; Chu, W.; Li, S.; Tu, Z.; Xu, J.; Mach, R. H. Functional assays to define agonists and antagonists of the sigma-2 receptor. Anal. Biochem., 2014, 448, 68-74.
12. Bowen, W. D.; Vilner, B. J.; Williams, W.; Bertha, C. M.; Kuehne, M. E.; Jacobson, A. E. Ibogaine and its congeners are sigma 2 receptor-selective ligands with moderate affinity. Eur. J. Pharmacol., 1995, 279(1), R1-3.
13. Gualtieri, F.; Bottalico, C.; Calandrella, A.; Dei, S.; Giovannoni, M. P.; Mealli, S.; Romanelli, M. N.; Scapecchi, S.; Teodori, E.; Galeotti, N.; Ghelardini, C.; Giotti, A.; Bartolinit, A. Presynaptic cholinergic modulators as potent cognition enhancers and analgesic drugs. 2. 2-Phenoxy-, 2-(phenylthio)-, and 2-(phenylamino) alkanoic acid esters. J. Med. Chem., 1994, 37(11), 1712-1719.
14. Mach, R. H.; Wu, L.; West, T.; Whirrett, B. R.; Childers, S. R. The analgesic tropane analogue (+/-)-SM 21 has a high affinity for sigma2 receptors. Life Sci., 1999, 64(10), PL131-137.
15. Cratteri, P.; Romanelli, M. N.; Cruciani, G.; Bonaccini, C.; Melani, F. GRIND-derived pharmacophore model for a series of alphatropanyl derivative ligands of the sigma-2 receptor. J. Comput. Aided Mol. Des., 2004, 18(5), 361-374.
16. Zampieri, D.; Grazia Mamolo, M.; Laurini, E.; Zanette, C.; Florio, C.; Collina, S.; Rossi, D.; Azzolina, O.; Vio, L. Substituted benzo[d]oxazol-2(3H)-one derivatives with preference for the sigma1 binding site. Eur. J. Med. Chem., 2009, 44(1), 124-130.
17. Zampieri, D.; Mamolo, M. G.; Laurini, E.; Florio, C.; Zanette, C.; Fermeglia, M.; Posocco, P.; Paneni, M. S.; Pricl, S.; Vio, L. Synthesis, biological evaluation, and three-dimensional in silico pharmacophore model for sigma(1) receptor ligands based on a series of substituted benzo[d]oxazol-2(3H)-one derivatives. J. Med. Chem., 2009, 52(17), 5380-5393.
18. Laurini, E.; Zampieri, D.; Mamolo, M. G.; Vio, L.; Zanette, C.; Florio, C.; Posocco, P.; Fermeglia, M.; Pricl, S. A 3Dpharmacophore model for sigma2 receptors based on a series of substituted benzo[d]oxazol-2(3H)-one derivatives. Bioorg. Med. Chem. Lett., 2010, 20(9), 2954-2957.
19. Froimowitz, M.; Pick, C. G.; Pasternak, G. W. Phenylmorphans and analogues: opioid receptor subtype selectivity and effect of conformation on activity. J. Med. Chem., 1992, 35(9), 1521-1525.
20. Bertha, C. M.; Mattson, M. V.; Flippen-Anderson, J. L.; Rothman, R. B.; Xu, H.; Cha, X. Y.; Becketts, K.; Rice, K. C. A marked change of receptor affinity of the 2-methyl-5-(3-hydroxyphenyl)morphans upon attachment of an (E)-8-benzylidene moiety: synthesis and evaluation of a new class of sigma receptor ligands. J. Med. Chem., 1994, 37(19), 3163-3170.
21. Bowen, W. D.; Bertha, C. M.; Vilner, B. J.; Rice, K. C. CB-64D and CB-184: ligands with high sigma 2 receptor affinity and subtype selectivity. Eur. J. Pharmacol., 1995, 278(3), 257-260.
22. Berardi, F.; Colabufo, N. A.; Giudice, G.; Perrone, R.; Tortorella, V.; Govoni, S.; Lucchi, L. New sigma and 5-HT1A receptor ligands: omega-(tetralin-1-yl)-n-alkylamine derivatives. J. Med. Chem., 1996, 39(1), 176-182.
23. Cassano, G.; Gasparre, G.; Niso, M.; Contino, M.; Scalera, V.; Colabufo, N. A. F281, synthetic agonist of the sigma-2 receptor, induces Ca2+ efflux from the endoplasmic reticulum and mitochondria in SK-N-SH cells. Cell Calcium, 2009, 45(4), 340-345.
24. Berardi, F.; Abate, C.; Ferorelli, S.; Uricchio, V.; Colabufo, N. A.; Niso, M.; Perrone, R. Exploring the importance of piperazine Natoms for sigma(2) receptor affinity and activity in a series of analogs of 1-cyclohexyl-4-[3-(5-methoxy-1, 2, 3, 4-tetrahydronaphthalen-1-yl)propyl]piperazine (PB28). J. Med. Chem., 2009, 52(23), 7817-7828.
25. Mesangeau, C.; Narayanan, S.; Green, A. M.; Shaikh, J.; Kaushal, N.; Viard, E.; Xu, Y. T.; Fishback, J. A.; Poupaert, J. H.; Matsumoto, R. R.; McCurdy, C. R. Conversion of a highly selective sigma-1 receptor-ligand to sigma-2 receptor preferring ligands with anticocaine activity. J. Med. Chem., 2008, 51(5), 1482-1486.
26. Mesangeau, C.; Amata, E.; Alsharif, W.; Seminerio, M. J.; Robson, M. J.; Matsumoto, R. R.; Poupaert, J. H.; McCurdy, C. R. Synthesis and pharmacological evaluation of indole-based sigma receptor ligands. Eur. J. Med. Chem., 2011, 46(10), 5154-5161.
27. Abate, C.; Mosier, P. D.; Berardi, F.; Glennon, R. A. A structureaffinity and comparative molecular field analysis of sigma-2 (sigma2) receptor ligands. Cent. Nerv. Syst. Agents Med. Chem., 2009, 9(3), 246-257.
28. Huang, Y.; Luedtke, R. R.; Freeman, R. A.; Wu, L.; Mach, R. H. Synthesis and structure-activity relationships of naphthamides as dopamine D3 receptor ligands. J. Med. Chem., 2001, 44(11), 1815-1826.
29. Mach, R. H.; Huang, Y.; Freeman, R. A.; Wu, L.; Vangveravong, S.; Luedtke, R. R. Conformationally-flexible benzamide analogues as dopamine D3 and sigma 2 receptor ligands. Bioorg. Med. Chem. Lett., 2004, 14(1), 195-202.
30. Xu, R.; Lever, J. R.; Lever, S. Z. Synthesis and in vitro evaluation of tetrahydroisoquinolinyl benzamides as ligands for sigma receptors. Bioorg. Med. Chem. Lett., 2007, 17(9), 2594-2597.
31. Fan, K. H.; Lever, J. R.; Lever, S. Z. Effect of structural modification in the amine portion of substituted aminobutyl-benzamides as ligands for binding sigma1 and sigma2 receptors. Bioorg. Med. Chem., 2011, 19(6), 1852-1859.
32. Abate, C.; Ferorelli, S.; Contino, M.; Marottoli, R.; Colabufo, N. A.; Perrone, R.; Berardi, F. Arylamides hybrids of two high-affinitysigma2 receptor ligands as tools for the development of PET radiotracers. Eur. J. Med. Chem., 2011, 46(9), 4733-4741.
33. Hajipour, A. R.; Guo, L. W.; Pal, A.; Mavlyutov, T.; Ruoho, A. E. Electron-donating para-methoxy converts a benzamideisoquinoline derivative into a highly Sigma-2 receptor selective ligand. Bioorg. Med. Chem., 2011, 19(24), 7435-7440.
34. Mamolo, M. G.; Zampieri, D.; Zanette, C.; Florio, C.; Collina, S.; Urbano, M.; Azzolina, O.; Vio, L. Substituted benzylaminoalkylindoles with preference for the sigma2 binding site. Eur. J. Med. Chem., 2008, 43(10), 2073-2081.
35. Yarim, M.; Koksal, M.; Schepmann, D.; Wunsch, B. Synthesis and in vitro Evaluation of Novel Indole-Based Sigma Receptors Ligands. Chem. Biol. Drug Des., 2011, 78(5), 869-875.
36. Gitto, R.; De Luca, L.; Ferro, S.; Scala, A.; Ronsisvalle, S.; Parenti, C.; Prezzavento, O.; Buemi, M. R.; Chimirri, A. From NMDA receptor antagonists to discovery of selective sigma(2) receptor ligands. Bioorg. Med. Chem., 2014, 22(1), 393-397.
37. Banister, S. D.; Moussa, I. A.; Jorgensen, W. T.; Chua, S. W.; Kassiou, M. Molecular hybridization of 4-azahexacyclo[5. 4. 1. 0(2, 6). 0(3, 10). 0(5, 9). 0(8, 11)]dodecane-3-ol with sigma (sigma) receptor ligands modulates off-target activity and subtype selectivity. Bioorg. Med. Chem. Lett., 2011, 21(12), 3622-3626.
38. Banister, S. D.; Rendina, L. M.; Kassiou, M. 7-Azabicyclo[2. 2. 1]heptane as a scaffold for the development of selective sigma-2 (sigma2) receptor ligands. Bioorg. Med. Chem. Lett., 2012, 22(12), 4059-4063.
39. Bonhaus, D. W.; Loury, D. N.; Jakeman, L. B.; To, Z.; DeSouza, A.; Eglen, R. M.; Wong, E. H. [3H]BIMU-1, a 5-hydroxytryptamine3 receptor ligand in NG-108 cells, selectively labels sigma-2 binding sites in guinea pig hippocampus. J. Pharmacol. Exp. Ther., 1993, 267(2), 961-970.
40. Vangveravong, S.; Xu, J.; Zeng, C.; Mach, R. H. Synthesis of Nsubstituted 9-azabicyclo[3. 3. 1]nonan-3alpha-yl carbamate analogs as sigma2 receptor ligands. Bioorg. Med. Chem., 2006, 14(20), 6988-6997.
41. Chu, W.; Xu, J.; Zhou, D.; Zhang, F.; Jones, L. A.; Wheeler, K. T.; Mach, R. H. New N-substituted 9-azabicyclo[3. 3. 1]nonan-3alpha-yl phenylcarbamate analogs as sigma2 receptor ligands: synthesis, in vitro characterization, and evaluation as PET imaging and chemosensitization agents. Bioorg. Med. Chem., 2009, 17(3), 1222-1231.
42. Rhoades, D. J.; Kinder, D. H.; Mahfouz, T. M. A comprehensive ligand based mapping of the sigma(2) receptor binding pocket. Med. Chem., 2014, 10(1), 98-121.
43. Cassano, G.; Gasparre, G.; Contino, M.; Niso, M.; Berardi, F.; Perrone, R.; Colabufo, N. A. The sigma-2 receptor agonist PB28 inhibits calcium release from the endoplasmic reticulum of SK-N-SH neuroblastoma cells. Cell Calcium, 2006, 40(1), 23-28.
44. Vilner, B. J.; Bowen, W. D. Modulation of cellular calcium by sigma-2 receptors: release from intracellular stores in human SKN-SH neuroblastoma cells. J. Pharmacol. Exp. Ther., 2000, 292(3), 900-911.
45. Zhang, H.; Cuevas, J. Sigma receptors inhibit high-voltageactivated calcium channels in rat sympathetic and parasympathetic neurons. J. Neurophysiol., 2002, 87(6), 2867-2879.
46. Lamy, C.; Scuvee-Moreau, J.; Dilly, S.; Liegeois, J. F.; Seutin, V. The sigma agonist 1, 3-di-o-tolyl-guanidine directly blocks SK channels in dopaminergic neurons and in cell lines. Eur. J. Pharmacol., 2010, 641(1), 23-28.
47. Garces-Ramirez, L.; Green, J. L.; Hiranita, T.; Kopajtic, T. A.; Mereu, M.; Thomas, A. M.; Mesangeau, C.; Narayanan, S.; McCurdy, C. R.; Katz, J. L.; Tanda, G. Sigma receptor agonists: receptor binding and effects on mesolimbic dopamine neurotransmission assessed by microdialysis. Biol. Psychiatry, 2011, 69(3), 208-217.
48. Miller, G. M. The emerging role of trace amine-associated receptor 1 in the functional regulation of monoamine transporters and dopaminergic activity. J. Neurochem., 2011, 116(2), 164-176.
49. Schmitt, K. C.; Reith, M. E. Regulation of the dopamine transporter: Aspects relevant to psychostimulant drugs of abuse. Ann. N. Y. Acad. Sci, 2010, 1187, 316-340.
50. Izenwasser, S.; Thompson-Montgomery, D.; Deben, S. E.; Chowdhury, I. N.; Werling, L. L. Modulation of amphetamine-stimulated (transporter mediated) dopamine release in vitro by sigma2 receptor agonists and antagonists. Eur. J. Pharmacol., 1998, 346(2-3), 189-196.
51. Weatherspoon, J. K.; Werling, L. L. Modulation of amphetaminestimulated[3H]dopamine release from rat pheochromocytoma (PC12) cells by sigma type 2 receptors. J. Pharmacol. Exp. Ther., 1999, 289(1), 278-284.
52. Derbez, A. E.; Mody, R. M.; Werling, L. L. Sigma(2)-receptor regulation of dopamine transporter via activation of protein kinase C. J. Pharmacol. Exp. Ther., 2002, 301(1), 306-314.
53. Nuwayhid, S. J.; Werling, L. L. Sigma2 (sigma2) receptors as a target for cocaine action in the rat striatum. Eur. J. Pharmacol., 2006, 535(1-3), 98-103.
54. Lever, J. R.; Miller, D. K.; Green, C. L.; Fergason-Cantrell, E. A.; Watkinson, L. D.; Carmack, T. L.; Fan, K. H.; Lever, S. Z. A selective sigma-2 receptor ligand antagonizes cocaine-induced hyperlocomotion in mice. Synapse, 2014, 68(2), 73-84.
55. Brown, T. K. Ibogaine in the treatment of substance dependence. Curr. Drug Abuse Rev., 2013, 6(1), 3-16.
56. Helsley, S.; Rabin, R. A.; Winter, J. C. Drug discrimination studies with ibogaine. Alkaloids Chem. Biol., 2001, 56, 63-77.
57. Glick, S. D.; Maisonneuve, I. S. Mechanisms of antiaddictive actions of ibogaine. Ann. N. Y. Acad. Sci., 1998, (844), 214-226.
58. Glick, S. D.; Maisonneuve, I. M.; Visker, K. E.; Fritz, K. A.; Bandarage, U. K.; Kuehne, M. E. 18-Methoxycoronardine attenuates nicotine-induced dopamine release and nicotine preferences in rats. Psychopharmacology (Berl), 1998, 139(3), 274-280.
59. Kourrich, S.; Hayashi, T.; Chuang, J. Y.; Tsai, S. Y.; Su, T. P.; Bonci, A. Dynamic interaction between sigma-1 receptor and Kv1. 2 shapes neuronal and behavioral responses to cocaine. Cell, 2013, 152(1-2), 236-247.
60. Fritz, M.; Klement, S.; El Rawas, R.; Saria, A.; Zernig, G. Sigma1 receptor antagonist BD1047 enhances reversal of conditioned place preference from cocaine to social interaction. Pharmacology, 2011, 87(1-2), 45-48.
61. Lever, J. R.; Miller, D. K.; Fergason-Cantrell, E. A.; Green, C. L.; Watkinson, L. D.; Carmack, T. L.; Lever, S. Z. Relationship between cerebral sigma-1 receptor occupancy and attenuation of cocaine's motor stimulatory effects in mice by PD144418. J. Pharmacol. Exp. Ther., 2014, 351(1), 153-163.
62. Neznamov, G. G.; Siuniakov, S. A.; Chumakov, D. V.; Mametova, L. E. [Aphobazol-new selective anxyolytic drug]. Zh. Nevrol. Psikhiatr. Im. S. S. Korsakova., 2005, 105(4), 35-40.
63. Seredenin, S. B.; Antipova, T. A.; Voronin, M. V.; Kurchashova, S. Y.; Kuimov, A. N. Interaction of afobazole with sigma1-receptors. Bull. Exp. Biol. Med., 2009, 148(1), 42-44.
64. Cuevas, J.; Rodriguez, A.; Behensky, A.; Katnik, C. Afobazole modulates microglial function via activation of both sigma-1 and sigma-2 receptors. J. Pharmacol. Exp. Ther., 2011, 339(1), 161-172.
65. Katnik, C.; Garcia, A.; Behensky, A. A.; Yasny, I. E.; Shuster, A. M.; Seredenin, S. B.; Petrov, A. V.; Seifu, S.; McAleer, J.; Willing, A.; Cuevas, J. Treatment with afobazole at delayed time points following ischemic stroke improves long-term functional and histological outcomes. Neurobiol. Dis., 2014, 62, 354-364.
66. Maurice, T.; Phan, V. L.; Noda, Y.; Yamada, K.; Privat, A.; Nabeshima, T. The attenuation of learning impairments induced after exposure to CO or trimethyltin in mice by sigma (sigma) receptor ligands involves both sigma1 and sigma2 sites. Br. J. Pharmacol., 1999, 127(2), 335-342.
67. Behensky, A. A.; Yasny, I. E.; Shuster, A. M.; Seredenin, S. B.; Petrov, A. V.; Cuevas, J. Stimulation of sigma receptors with afobazole blocks activation of microglia and reduces toxicity caused by amyloid-beta25-35. J. Pharmacol. Exp. Ther., 2013, 347(2), 458-467.
68. Iniguez, M. A.; Punzon, C.; Nieto, R.; Burgueno, J.; Vela, J. M.; Fresno, M. Inhibitory effects of sigma-2 receptor agonists on T lymphocyte activation. Front. Pharmacol., 2013, 4, 23. http://journal. frontiersin. org/Journal/10. 3389/fphar. 2013. 00023/full
69. Sanchez, C.; Arnt, J.; Costall, B.; Kelly, M. E.; Meier, E.; Naylor, R. J.; Perregaard, J. The selective sigma2-ligand Lu 28-179 has potent anxiolytic-like effects in rodents. J. Pharmacol. Exp. Ther., 1997, 283(3), 1323-1332.
70. Heading, C. Siramesine H Lundbeck. Curr Opin Investig Drugs, 2001, 2(2), 266-270.
71. Sanchez, C.; Papp, M. The selective sigma2 ligand Lu 28-179 has an antidepressant-like profile in the rat chronic mild stress model of depression. Behav. Pharmacol., 2000, 11(2), 117-124.
72. Kavanaugh, M. P.; Tester, B. C.; Scherz, M. W.; Keana, J. F.; Weber, E. Identification of the binding subunit of the sigma-type opiate receptor by photoaffinity labeling with 1-(4-azido-2-methyl[6-3H]phenyl)-3-(2-methyl[4, 6-3H]phenyl)guanidine. Proc. Natl. Acad. Sci. U. S. A., 1988, 85(8), 2844-2848.
73. Mavlyutov, T. A.; Ruoho, A. E. Ligand-dependent localization and intracellular stability of sigma-1 receptors in CHO-K1 cells. J. Mol. Signal, 2007, 2, 8.
74. Wilke, R. A.; Mehta, R. P.; Lupardus, P. J.; Chen, Y.; Ruoho, A. E.; Jackson, M. B. Sigma receptor photolabeling and sigma receptormediated modulation of potassium channels in tumor cells. J. Biol. Chem., 1999, 274(26), 18387-18392.
75. Fontanilla, D.; Johannessen, M.; Hajipour, A. R.; Cozzi, N. V.; Jackson, M. B.; Ruoho, A. E. The hallucinogen N, Ndimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator. Science, 2009, 323(5916), 934-937.
76. Chen, Y.; Hajipour, A. R.; Sievert, M. K.; Arbabian, M.; Ruoho, A. E. Characterization of the cocaine binding site on the sigma-1 receptor. Biochemistry, 2007, 46(11), 3532-3542.
77. Fontanilla, D.; Hajipour, A. R.; Pal, A.; Chu, U. B.; Arbabian, M.; Ruoho, A. E. Probing the steroid binding domain-like I (SBDLI) of the sigma-1 receptor binding site using N-substituted photoaffinity labels. Biochemistry, 2008, 47(27), 7205-7217.
78. Xu, J.; Tu, Z.; Jones, L. A.; Vangveravong, S.; Wheeler, K. T.; Mach, R. H. [3H]N-[4-(3, 4-dihydro-6, 7-dimethoxyisoquinolin-2(1H)-yl)butyl]-2-methoxy-5-methyl benzamide: A novel sigma-2 receptor probe. Eur. J. Pharmacol., 2005, 525(1-3), 8-17.
79. Colabufo, N. A.; Abate, C.; Contino, M.; Inglese, C.; Ferorelli, S.; Berardi, F.; Perrone, R. Tritium radiolabelling of PB28, a potent sigma-2 receptor ligand: pharmacokinetic and pharmacodynamic characterization. Bioorg. Med. Chem. Lett., 2008, 18(6), 2183-2187.
80. Kassiou, M.; Dannals, R. F.; Liu, X.; Wong, D. F.; Ravert, H. T.; Scheffel, U. A. Synthesis and in vivo evaluation of a new PET radioligand for studying sigma-2 receptors. Bioorg. Med. Chem., 2005, 13(11), 3623-3626.
81. Abate, C.; Selivanova, S. V.; Muller, A.; Kramer, S. D.; Schibli, R.; Marottoli, R.; Perrone, R.; Berardi, F.; Niso, M.; Ametamey, S. M. Development of 3, 4-dihydroisoquinolin-1(2H)-one derivatives for the Positron Emission Tomography (PET) imaging of sigma(2) receptors. Eur. J. Med. Chem., 2013, 69, 920-930.
82. Chen, X.; Cui, M. C.; Deuther-Conrad, W.; Tu, Y. F.; Ma, T.; Xie, Y.; Jia, B.; Li, Y.; Xie, F.; Wang, X.; Steinbach, J.; Brust, P.; Liu, B. L.; Jia, H. M. Synthesis and biological evaluation of a novel 99mTc cyclopentadienyl tricarbonyl complex ([(Cp-R)99mTc(CO)3]) for sigma-2 receptor tumor imaging. Bioorg. Med. hem. Lett., 2012, 22(20), 6352-6357.